Related Experiment Video
Updated: May 17, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Clinical trials must cope better with multiplicity
1Statistics Collaborative, Washington, DC, USA.
Nature Medicine
|November 9, 2012
Summary
Researchers often use strict statistical methods in clinical trials that can hide real findings. Choosing the right statistical analysis is crucial for accurate trial results and avoiding misleading data.
Area of Science:
- Biostatistics
- Clinical Trial Design
- Medical Research Methodology
Background:
- Clinical trials frequently investigate multiple research questions simultaneously.
- Overly stringent statistical methods are sometimes employed to prevent false positives from multiple testing.
- These conservative statistical approaches can inadvertently mask genuine treatment effects.
Purpose of the Study:
- To highlight the potential drawbacks of overly strict statistical methods in clinical trials.
- To advocate for a more nuanced approach to selecting statistical analyses in multi-question trials.
- To emphasize the importance of balancing the control of chance findings with the detection of true effects.
Main Methods:
- The abstract discusses the common practice of multiple testing in clinical trials.
- It critiques the application of overly conservative statistical adjustments.
- It emphasizes the need for careful consideration of appropriate statistical analysis types.
Main Results:
- Strict statistical devices, while intended to prevent chance findings, can obscure significant results.
- A mismatch between the statistical method and the trial's complexity can lead to masking true effects.
- Inappropriate statistical analysis poses a risk to the validity of clinical trial outcomes.
Conclusions:
- Researchers must carefully select statistical analyses that are appropriate for the specific questions and design of their clinical trials.
- A more balanced approach is needed to avoid masking true effects while still addressing the issue of multiple comparisons.
- Optimizing statistical methodology is key to ensuring the reliability and interpretability of clinical trial data.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:11Bioavailability Study Design: Single Versus Multiple Dose Studies
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:16Crossover Experiments
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.